$41.3 Million is the total value of Healthcare Value Capital, LLC's 12 reported holdings in Q3 2018. The portfolio turnover from Q2 2018 to Q3 2018 was 23.1% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| GILD | GILEAD SCIENCES INC | $7,721,000 | +9.0% | 100,000 | 0.0% | 18.67% | -7.0% | |
| AMRN | Sell | AMARIN CORP PLCspons adr new | $7,322,000 | +373.9% | 450,000 | -10.0% | 17.71% | +304.3% |
| TYME | Buy | TYME TECHNOLOGIES INC | $6,047,000 | -7.8% | 2,175,000 | +4.8% | 14.62% | -21.3% |
| GSK | GLAXOSMITHKLINE PLCsponsored adr | $4,017,000 | -0.3% | 100,000 | 0.0% | 9.72% | -15.0% | |
| AGN | ALLERGAN PLC | $3,810,000 | +14.3% | 20,000 | 0.0% | 9.21% | -2.5% | |
| FLDM | FLUIDIGM CORP DEL | $3,371,000 | +25.7% | 450,000 | 0.0% | 8.15% | +7.2% | |
| NVLNF | Sell | NOVELION THERAPEUTICS INC | $2,994,000 | -38.1% | 1,011,487 | -23.0% | 7.24% | -47.1% |
| VKTX | VIKING THERAPEUTICS INC | $2,613,000 | +83.5% | 150,000 | 0.0% | 6.32% | +56.5% | |
| BIS | PROSHARES TRultsh nasd biot | $2,345,000 | -19.7% | 150,000 | 0.0% | 5.67% | -31.5% | |
| ATRS | Buy | ANTARES PHARMA INC | $840,000 | +225.6% | 250,000 | +150.0% | 2.03% | +177.8% |
| LCI | New | LANNET INCcall | $238,000 | – | 50,000 | +100.0% | 0.58% | – |
| APRI | APRICUS BIOSCIENCES INC | $31,000 | -20.5% | 100,000 | 0.0% | 0.08% | -32.4% | |
| ATRS | Exit | ANTARES PHARMA INCcall | $0 | – | -100,000 | -100.0% | -0.73% | – |
| AMRN | Exit | AMARIN CORP PLCcall | $0 | – | -100,000 | -100.0% | -0.88% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2018-11-14
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| GILEAD SCIENCES INC | 20 | Q3 2021 | 31.3% |
| GLAXOSMITHKLINE PLC | 20 | Q3 2021 | 16.1% |
| PFIZER INC | 19 | Q3 2021 | 17.9% |
| TYME TECHNOLOGIES INC | 17 | Q3 2021 | 40.3% |
| ASTRAZENECA PLC | 14 | Q3 2021 | 12.9% |
| QUEST DIAGNOSTICS INC | 14 | Q3 2016 | 9.5% |
| CRYOLIFE INC | 13 | Q1 2017 | 6.6% |
| ANTARES PHARMA INC | 13 | Q3 2021 | 6.7% |
| AMARIN CORP PLC | 13 | Q3 2021 | 4.9% |
| CYTOKINETICS INC | 13 | Q3 2016 | 1.7% |
View Healthcare Value Capital, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| NOVELION THERAPEUTICS INC. | September 20, 2019 | 1,400,000 | 7.4% |
View Healthcare Value Capital, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2021-11-15 |
| 13F-HR | 2021-08-16 |
| 13F-HR | 2021-05-17 |
| 13F-HR | 2021-02-16 |
| 13F-HR | 2020-11-16 |
| 13F-HR | 2020-08-14 |
| 13F-HR | 2020-05-15 |
| 13F-HR | 2020-02-14 |
| 13F-HR | 2019-11-14 |
| SC 13D/A | 2019-09-20 |
View Healthcare Value Capital, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.